Anticancer Effect of Metformin in Herceptin-Conjugated Liposome for Breast Cancer

Metformin (MET) is an anti-diabetic drug effective against breast cancer, targeting breast cancer stem cells (BCSCs). MET-encapsulating liposome (LP-MET) and Herceptin-conjugated LP-MET (Her-LP-MET) were evaluated for their anti-cancer effect in vitro and in vivo. Size and zeta potentials of LP-MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Ji-Yeon, Shin, Dae Hwan, Kim, Jin-Seok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7023063/
https://www.ncbi.nlm.nih.gov/pubmed/31877620
http://dx.doi.org/10.3390/pharmaceutics12010011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7023063/
https://www.ncbi.nlm.nih.gov/pubmed/31877620
http://dx.doi.org/10.3390/pharmaceutics12010011

Ejemplares similares